NeuroDerm Ltd. Announces Enrollment in a Phase 2 Study of ND0612, a Continuous Levodopa/Carbidopa Drug for the Treatment of Parkinson's Disease
4/15/2013 10:10:03 AM
More...
|
NeuroDerm Ltd. Announces Positive Results of a Phase I Study of ND0612 for the Treatment of Parkinson's Disease
3/4/2013 9:43:19 AM
More...
|
NeuroDerm Ltd. Announces Positive Results of a Phase II Study of ND0611 Dermal Patch in Patients with Parkinson's Disease
11/9/2011 6:44:49 AM
More...
|
NeuroDerm Ltd. Raises $2.5 Million in Series A Financing
7/23/2007 11:35:01 AM
More...
|